RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

Being malcontent is a bad option, because it doesn't improve things anyway.

A possibility re: the delay is that the treatment created other respiratory anomalies, such as periodic breathing, which might give rise to more frequent, but shorter apneas. This is a possible outcome if loop gain were increased, which is what I'd expect from upregulation of glutamatergic transmission.